Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (331-340 of 692) with videos related to

Pageof 70
Sort By:
European Urology|June 1, 2013
Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literatureSanoj Punnen, Matthew R Cooperberg, Anthony V D'Amico, et al.
Neuroimage|February 19, 2008
Age effects on hippocampal structural changes in old men: the HAASYuan Xu, Daniel J Valentino, Ann I Scher, et al.
Clinical Chemistry and Laboratory Medicine|June 22, 2012
Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responsesDavid Ulmert, Andrew J Vickers, Howard I Scher, et al.
European Urology|November 22, 2011
Biomarkers in the management and treatment of men with metastatic castration-resistant prostate cancerAndrew J Armstrong, Mario A Eisenberger, Susan Halabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancerM C Graham, H I Scher, G B Liu, et al.
Seminars in Oncology|March 10, 2001
A potential role for activated HER-2 in prostate cancerD B Agus, R W Akita, W D Fox, et al.
Neurology|March 19, 2017
Epidemiology and prognosis of mild traumatic brain injury in returning soldiers: A cohort studyKaren Schwab, Heidi P Terrio, Lisa A Brenner, et al.
Cancer Journal (Sudbury, Mass.)|October 18, 2016
Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer PatientsDaniel C Danila, Aliaksandra Samoila, Chintan Patel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 10, 2004
Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer developmentGloria E Mao, Victor E Reuter, Carlos Cordon-Cardo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trialD F Bajorin, J A McCaffrey, S Hilton, et al.
Pageof 70

Showing results (331-340 of 692) with videos related to

Sort By:
Pageof 70
European Urology|June 1, 2013
Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literatureSanoj Punnen, Matthew R Cooperberg, Anthony V D'Amico, et al.
Neuroimage|February 19, 2008
Age effects on hippocampal structural changes in old men: the HAASYuan Xu, Daniel J Valentino, Ann I Scher, et al.
Clinical Chemistry and Laboratory Medicine|June 22, 2012
Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responsesDavid Ulmert, Andrew J Vickers, Howard I Scher, et al.
European Urology|November 22, 2011
Biomarkers in the management and treatment of men with metastatic castration-resistant prostate cancerAndrew J Armstrong, Mario A Eisenberger, Susan Halabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancerM C Graham, H I Scher, G B Liu, et al.
Seminars in Oncology|March 10, 2001
A potential role for activated HER-2 in prostate cancerD B Agus, R W Akita, W D Fox, et al.
Neurology|March 19, 2017
Epidemiology and prognosis of mild traumatic brain injury in returning soldiers: A cohort studyKaren Schwab, Heidi P Terrio, Lisa A Brenner, et al.
Cancer Journal (Sudbury, Mass.)|October 18, 2016
Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer PatientsDaniel C Danila, Aliaksandra Samoila, Chintan Patel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 10, 2004
Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer developmentGloria E Mao, Victor E Reuter, Carlos Cordon-Cardo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trialD F Bajorin, J A McCaffrey, S Hilton, et al.
Pageof 70